sivelestat has been researched along with Adenocarcinoma, Basal Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwasaki, T; Kimura, H; Kitada, S; Maekura, R; Mori, M; Naka, N; Nakagawa, M; Nakazawa, Y; Namba, Y; Niinaka, M; Okada, T; Yano, Y; Yokota, S | 1 |
Inada, M; Ogawa, M; Yamashita, J | 1 |
An, XY; Kamohara, H; Mita, S; Ogawa, M; Sakamoto, K | 1 |
3 other study(ies) available for sivelestat and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
[A case of lung adenocarcinoma effectively treated with sivelestat and corcicosteroid for drug-induced lung disease due to gefitinib].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Gefitinib; Glycine; Humans; Lung Diseases; Lung Neoplasms; Male; Prednisolone; Quinazolines; Serine Proteinase Inhibitors; Sulfonamides | 2008 |
Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Female; Glycine; Humans; Leukocyte Elastase; Lung Neoplasms; Mice; Mice, SCID; Neutrophils; Serine Proteinase Inhibitors; Sulfonamides; Tumor Cells, Cultured | 1997 |
Neutrophil elastase inhibitor (ONO-5046.Na) suppresses the proliferation, motility and chemotaxis of a pancreatic carcinoma cell line, Capan-1.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Movement; Chemotaxis; Glycine; Humans; Leukocyte Elastase; Pancreatic Neoplasms; Serine Proteinase Inhibitors; Sulfonamides; Tumor Cells, Cultured | 1997 |